Cargando…
Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines
IMPORTANCE: In April 2021, the US Department of Health and Human Services (HHS) released practice guidelines exempting educational requirements to obtain a Drug Addiction Treatment Act (DATA) waiver to treat up to 30 patients with opioid use disorder with buprenorphine. OBJECTIVE: To compare demogra...
Autores principales: | Jones, Christopher M., Olsen, Yngvild, Ali, Mir M., Sherry, Tisamarie B., Mcaninch, Jana, Creedon, Timothy, Juliana, Patti, Jacobus-Kantor, Laura, Baillieu, Robert, Diallo, Mamadou Misbaou, Thomas, Anita, Gandotra, Neeraj, Sokolowska, Marta, Ling, Shari, Compton, Wilson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362471/ https://www.ncbi.nlm.nih.gov/pubmed/37477926 http://dx.doi.org/10.1001/jamahealthforum.2023.1982 |
Ejemplares similares
-
National trends in buprenorphine prescribing before and during the COVID-19 pandemic
por: Ali, Mir M., et al.
Publicado: (2023) -
Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver
por: Lanham, Holly J., et al.
Publicado: (2022) -
Analysis of US County Characteristics and Clinicians With Waivers to Prescribe Buprenorphine After Changes in Federal Education Requirements
por: Nguyen, Thuy, et al.
Publicado: (2022) -
Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
por: Rowe, Christopher L., et al.
Publicado: (2022) -
Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes
por: Hirchak, Katherine A., et al.
Publicado: (2022)